CVS · Consumer

CVS HEALTH Corp

Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: what to focus on this earnings window

News · 2026-08-07

• Liquidity and Debt PositionImportance 37 · Surprise 42
  Moody’s revised CVS Health’s credit outlook from stable to positive while affirming its Baa3 senior unsecured rating. The revised outlook reflects progress in the health-insurance turnaround, membership adjustments,…

News · 2026-08-06

• PBM Regulatory RiskImportance 39 · Surprise 42
  Third-party reporting identified continuing regulatory uncertainty for CVS’s Caremark pharmacy-benefit-management business. Coverage highlighted potential 2027 pressure from changes to the 340B pharmacy program and…

10-Q · 2026-08-05

• Legacy Litigation ChargesImportance 72 · Surprise 100
  CVS Health recorded $1.2 billion of legacy litigation charges during the six months ended June 30, 2025 related to two court decisions concerning past business practices. The charges included $929 million in the…
• Liquidity and Cash PositionImportance 69 · Surprise 64
  CVS Health held approximately $11.3 billion of cash and cash equivalents as of June 30, 2026, including approximately $2.7 billion at the parent company or unrestricted subsidiaries. Operating cash flow increased 64.2%…
• Operating Income and MarginsImportance 57 · Surprise 64
  Consolidated operating income increased 97.5% to $4.7 billion in the second quarter and 63.0% to $9.4 billion for the first six months of 2026. Consolidated operating margin expanded to 4.4% from 2.4% in the quarter…
• Medicare Advantage Payment OutlookImportance 56 · Surprise 68
  On April 6, 2026, the U.S. Centers for Medicare & Medicaid Services issued final 2027 Medicare Advantage payment rates. The final rates imply an expected average 2.48% revenue increase for the Medicare Advantage…
• Income Tax Rate ChangesImportance 55 · Surprise 82
  The effective income tax rate decreased to 24.7% in the second quarter of 2026 from 38.5% in the second quarter of 2025. For the first six months, the effective rate declined to 24.8% from 34.5%. The lower rates were…
• Revenue Performance and MixImportance 54 · Surprise 40
  Health Services revenue increased 11.5% to $51.8 billion in the second quarter and 11.3% to $100.0 billion for the first six months, driven by pharmacy drug mix and brand inflation. Health Care Benefits revenue rose…
• Pharmacy Channel DemandImportance 54 · Surprise 40
  Health Services revenue grew 11.5% in the second quarter and 11.3% for the first six months, driven primarily by pharmacy drug mix and brand inflation, despite pharmacy client price improvements. Mail and specialty…
• Capital Return ProgramImportance 50 · Surprise 24
  CVS Health had two active share repurchase authorizations totaling $20.0 billion as of June 30, 2026. The November 2022 program had $10.0 billion remaining, while the December 2021 program had $1.5 billion remaining.…
• Operating Expense TrendsImportance 39 · Surprise 50
  Consolidated operating expenses decreased $166 million, or 1.5%, to $11.0 billion in the second quarter and $244 million, or 1.1%, to $22.0 billion for the first six months. The quarterly reduction primarily reflected…
• Medical Membership TrendsImportance 39 · Surprise 50
  CVS Health had 26.0 million medical members as of June 30, 2026, including 4.2 million Medicare Advantage members, 1.2 million Medicare Supplement members, 4.3 million Medicaid members, and 18.3 million Commercial…
• PBM Legislative RestrictionsImportance 37 · Surprise 42
  Comprehensive legislation and regulations governing pharmacy benefit manager activities have been proposed or enacted in a majority of states and at the federal level. Certain states have enacted or are considering…
• Medical Benefit RatioImportance 33 · Surprise 50
  Health Care Benefits’ medical benefit ratio decreased 250 basis points to 87.4% in the second quarter of 2026 from 89.9% in the prior year. The six-month medical benefit ratio declined 260 basis points to 86.0% from…
• Medical Utilization PressureImportance 29 · Surprise 24
  Medical utilization remained elevated in the second quarter of 2026, creating potential pressure on the Health Care Benefits segment and CVS Healths health care delivery assets. Management stated that utilization…
• PBM Rebate and Pricing PressureImportance 29 · Surprise 24
  CVS Caremark continues to share a larger portion of pharmaceutical-manufacturer rebates, fees and discounts with clients and typically provides minimum pricing guarantees. Management said these guarantees cannot always…
• Interest Rate and Refinancing ExposureImportance 29 · Surprise 24
  As of June 30, 2026, CVS Health’s long-term debt was rated “BBB” by Fitch, “Baa3” by Moody’s and “BBB” by S&P. Fitch maintained a “Negative” outlook, while Moody’s outlook was “Stable” and S&P changed its outlook from…
• Retail Pharmacy DemandImportance 25 · Surprise 32
  Pharmacy same-store sales increased 2.9% in the second quarter and 3.0% for the first six months, supported by pharmacy drug mix, brand inflation and prescription-volume growth. Pharmacy same-store prescription volume…
• 340B Program UncertaintyImportance 23 · Surprise 24
  The federal 340B drug pricing program remains a dynamic regulatory environment. CVS Health stated that developments in the program may continue to affect its Health Services segment, which provides administrative,…
• Tariff and Inflation ExposureImportance 23 · Surprise 24
  CVS Health identified inflation, new or changed tariffs, and U.S. trade relations with foreign countries as factors that could increase costs and disrupt supply chains. These effects could adversely affect consumer…
• Liquidity and Debt PositionImportance 19 · Surprise 6
  CVS Health had no commercial paper outstanding and no borrowings under its three unsecured back-up revolving credit facilities as of June 30, 2026. Each facility provides $2.5 billion of capacity and expires in May…
• DividendsImportance 19 · Surprise 6
  CVS Health declared a quarterly cash dividend of $0.665 per share in the three months ended June 30, 2026, unchanged from the same period in 2025. Cash dividends declared totaled $1.33 per share for the six months…

Earnings call · 2026-08-05

• Guidance and OutlookImportance 95 · Surprise 92
  CVS raised full-year 2026 adjusted EPS guidance by $0.60, or 8%, to $7.90-$8.10. Full-year revenue guidance is now at least $414 billion, and operating cash flow guidance increased by $2 billion to at least $11.5…
• Cash Flow and LiquidityImportance 92 · Surprise 84
  CVS generated approximately $10.6 billion of operating cash flow in the first half of 2026 from strong earnings and working-capital improvements. Management raised full-year operating cash flow guidance to at least…
• Segment ProfitabilityImportance 57 · Surprise 56
  Second-quarter adjusted operating income was approximately $5.2 billion, up 35% year over year, with growth across all operating segments. Health Care Benefits produced approximately $2.4 billion of adjusted operating…
• Caremark Membership DeclineImportance 51 · Surprise 50
  Management expects Caremark membership to decline in 2027 as the company takes a disciplined approach to client renewals, underwriting and contracting structures during the transition toward lowest-net-cost pricing.…
• Revenue Performance and MixImportance 49 · Surprise 32
  CVS Health generated more than $106 billion of second-quarter 2026 revenue, up over 7% year over year. Health Care Benefits revenue exceeded $37 billion, up over 3%, primarily from government business growth that was…
• PBM Regulatory RiskImportance 47 · Surprise 60
  CVS expects recent legislation and regulatory developments, including its proposed settlement with the FTC, to accelerate Caremark's transition toward net-cost pricing models. Management said the transition is intended…
• AI Technology InvestmentImportance 46 · Surprise 42
  CVS committed more than $20 billion to technology investments over the next decade, with management emphasizing responsible AI deployment, privacy protection and return on investment. Current initiatives include…
• Retail Pharmacy Pricing PressureImportance 40 · Surprise 42
  CVS Pharmacy is addressing reimbursement pressure through a cost-based pricing approach intended to produce more sustainable reimbursement and better align payers with the value of community pharmacy services. Pharmacy…
• Retail Pharmacy DemandImportance 39 · Surprise 50
  CVS Pharmacy reported increased prescription volume, supported partly by prescription share gains from the Rite Aid transaction completed in 2025. Pharmacy and Consumer Wellness same-store prescription volumes…
• 340B Program UncertaintyImportance 37 · Surprise 42
  Health Services experienced pressure in its 340B business during the second quarter of 2026, although broader Caremark outperformance fully offset the impact for the quarter. Management attributed the pressure partly…
• AI Adoption RecognitionImportance 34 · Surprise 42
  CVS Health is deploying AI across consumer engagement, claims processing, provider interactions, pharmacy operations and clinical quality. The targeted launch of Health100 includes Haio, an AI-powered assistant…
• GLP-1 Distribution ExpansionImportance 31 · Surprise 42
  Demand for GLP-1 therapies for weight loss is growing, with consumers prioritizing affordability, access and convenience. CVS Health is expanding access through Caremark formulary actions, MinuteClinic’s 24/7 virtual…
• Litigation and Legal RiskImportance 31 · Surprise 42
  CVS and other parties are challenging laws in Arkansas and Tennessee that management characterized as unconstitutional and potentially harmful to pharmacy access. CVS said the laws could make care more expensive, less…
• Medical Cost Trend / Benefit RatioImportance 25 · Surprise 32
  Health Care Benefits reported a second-quarter medical benefit ratio of 87.4%, supported by medical cost management and disciplined pricing. Changes in the individual exchange risk-adjustment position for the 2025 plan…
• Medical Membership TrendsImportance 25 · Surprise 32
  Health Care Benefits medical membership was approximately 26 million at quarter-end, down about 700,000 year over year. The decline was primarily caused by CVS Health’s exit from the individual exchange business,…
• No Surprises Act Dispute ResolutionImportance 20 · Surprise 24
  CVS said independent dispute resolution under the federal No Surprises Act is an included component of medical cost trend and has been reflected in its 2026 planning. The company is bringing selected providers into its…
• Specialty Pharmacy Market PositionImportance 17 · Surprise 24
  CVS Specialty is positioned as a leading specialty pharmacy serving complex patients across their full therapy journeys. Management attributes its differentiation to clinical expertise, data and analytics, personalized…
• DividendsImportance 13 · Surprise 6
  CVS returned over $1.7 billion to shareholders through dividends during the first half of 2026. The company ended the quarter with approximately $2.7 billion of cash at the parent and unrestricted subsidiaries. The…

8-K · 2026-08-05

• Debt and Capital AllocationImportance 89 · Surprise 82
  Long-term debt declined to $61.410 billion at June 30, 2026, consisting of $1.958 billion current debt and $59.452 billion long-term debt, versus $64.570 billion at December 31, 2025. CVS Health repaid $3.287 billion…
• Guidance and OutlookImportance 67 · Surprise 76
  CVS Health raised full-year 2026 GAAP diluted EPS guidance to $6.84-$7.04 from $6.24-$6.44. Adjusted EPS guidance increased to $7.90-$8.10 from $7.30-$7.50, and cash flow from operations guidance increased to at least…
• Operating Expense TrendsImportance 59 · Surprise 48
  Consolidated operating expenses declined $166 million, or 1.5%, to $11.046 billion in the second quarter despite revenue growth of 7.3%. Health Services operating expenses fell $236 million, or 20.2%, to $934 million,…
• Segment ProfitabilityImportance 57 · Surprise 64
  Consolidated second-quarter operating income increased 97.5% to $4.703 billion from $2.381 billion, including the absence of $833 million in prior-year legacy litigation charges. Adjusted operating income increased…
• Cash Flow and LiquidityImportance 56 · Surprise 46
  Cash flow from operations reached $10.594 billion in the first six months of 2026, up from $6.453 billion in the prior-year period. Cash and cash equivalents increased to $11.329 billion at June 30, 2026 from $8.453…
• Pharmacy Demand And PricingImportance 54 · Surprise 40
  Health Services revenue increased 11.5% to $51.8 billion, primarily reflecting pharmacy drug mix and brand inflation, partly offset by continued pharmacy client price improvements. Pharmacy claims processed were…
• Medical Cost Trend / Benefit RatioImportance 49 · Surprise 32
  Health Care Benefits’ second-quarter medical benefit ratio declined to 87.4% from 89.9%, a 250-basis-point improvement. The improvement primarily reflected better underlying performance in the Government business and…
• Government Membership GrowthImportance 49 · Surprise 32
  Health Care Benefits revenue increased 3.5% year over year to $37.5 billion, primarily driven by growth in the Government business. Government premium revenue increased 9.9% to $28.5 billion in the quarter and 10.7%…
• Retail Pharmacy Pricing PressureImportance 49 · Surprise 32
  Pharmacy & Consumer Wellness revenue increased only 0.7% year over year to $33.8 billion despite a 4.3% increase in prescriptions filled. Regulatory-related price reductions on certain drugs, recent generic…
• Agentic AI Claims ProcessingImportance 46 · Surprise 66
  CVS Health is deploying agentic AI on a secure call-center platform for members and providers engaging with Aetna and CVS Caremark. Aetna launched the second generation of its Claims Assist Manager, an AI-powered…
• AI Adoption RecognitionImportance 46 · Surprise 66
  CVS Health is deploying agentic AI on a secure call-center platform to streamline interactions for members and providers engaging with Aetna and CVS Caremark. Aetna’s second-generation Claims Assist Manager is an…
• Income Tax Rate ChangesImportance 45 · Surprise 64
  The second-quarter income tax provision increased to $982 million from $634 million, while pretax income increased to $3.977 billion from $1.647 billion. The implied quarterly effective tax rate declined to…
• Revenue Performance and MixImportance 42 · Surprise 14
  Second-quarter total revenue increased 7.3% year over year to $106.096 billion from $98.915 billion, while six-month revenue rose $13.019 billion to $206.522 billion. Products generated $66.219 billion, premiums…
• Regulatory Drug PricingImportance 37 · Surprise 42
  CVS Health launched a GLP-1 support program across CVS Pharmacy and MinuteClinic locations, including expanded pharmacy assistance and a $29 MinuteClinic virtual visit for eligible adults. CVS Pharmacy participates in…
• Gross Margin DriversImportance 36 · Surprise 40
  Health Services second-quarter gross profit increased $265 million, or 11.7%, to $2.537 billion, while gross margin remained 4.9%. Pharmacy & Consumer Wellness gross profit increased $507 million, or 8.4%, to $6.534…
• GLP-1 Support ExpansionImportance 31 · Surprise 42
  CVS Health launched a comprehensive GLP-1 support approach across CVS Pharmacy and MinuteClinic locations. Expanded pharmacy support is intended to help patients access GLP-1 treatments and remain on therapy, while a…
• Litigation and Legal RiskImportance 28 · Surprise 42
  CVS Health reported that the prior-year quarter included $833 million of legacy litigation charges related to two court decisions involving past business practices. The charges affected the Health Services and Pharmacy…

News · 2026-08-05

• Caremark Membership DeclineImportance 32 · Surprise 24
  CVS Health's Caremark pharmacy-benefit-management business experienced a decline in membership during the second quarter. The decline creates pressure on the scale and customer base of the company's indirect…
• GLP-1 Distribution Channels ExpansionImportance 31 · Surprise 42
  CVS Health is expanding direct-to-consumer access to FDA-approved GLP-1 medications through its CVS Health app, MinuteClinic digital visits and approximately 9,000 CVS Pharmacy locations. A collaboration with Eli Lilly…
• GLP-1 Lilly PartnershipImportance 31 · Surprise 42
  CVS Health expanded its direct-to-consumer weight-management program through a collaboration with Eli Lilly and Company. Eligible patients seeking Lilly’s Zepbound and Foundayo can access transparent pricing through…